Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review
- PMID: 28806794
- DOI: 10.7326/M17-0477
Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review
Abstract
Background: Cannabis is available from medical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet its efficacy in treating PTSD symptoms remains uncertain.
Purpose: To identify ongoing studies and review existing evidence regarding the benefits and harms of plant-based cannabis preparations in treating PTSD in adults.
Data sources: MEDLINE, the Cochrane Library, and other sources from database inception to March 2017.
Study selection: English-language systematic reviews, trials, and observational studies with a control group that reported PTSD symptoms and adverse effects of plant-based cannabis use in adults with PTSD.
Data extraction: Study data extracted by 1 investigator was checked by a second reviewer; 2 reviewers independently assessed study quality, and the investigator group graded the overall strength of evidence by using standard criteria.
Data synthesis: Two systematic reviews, 3 observational studies, and no randomized trials were found. The systematic reviews reported insufficient evidence to draw conclusions about benefits and harms. The observational studies found that compared with nonuse, cannabis did not reduce PTSD symptoms. Studies had medium and high risk of bias, and overall evidence was judged insufficient. Two randomized trials and 6 other studies examining outcomes of cannabis use in patients with PTSD are ongoing and are expected to be completed within 3 years.
Limitation: Very scant evidence with medium to high risk of bias.
Conclusion: Evidence is insufficient to draw conclusions about the benefits and harms of plant-based cannabis preparations in patients with PTSD, but several ongoing studies may soon provide important results.
Primary funding source: U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Quality Enhancement Research Initiative. (PROSPERO: CRD42016033623).
Comment in
-
Cannabis for Pain and Posttraumatic Stress Disorder: More Consensus Than Controversy or Vice Versa?Ann Intern Med. 2017 Sep 5;167(5):355-356. doi: 10.7326/M17-1713. Epub 2017 Aug 15. Ann Intern Med. 2017. PMID: 28806789 No abstract available.
Similar articles
-
The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.Ann Intern Med. 2017 Sep 5;167(5):319-331. doi: 10.7326/M17-0155. Epub 2017 Aug 15. Ann Intern Med. 2017. PMID: 28806817 Review.
-
Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms.J Nerv Ment Dis. 2020 Aug;208(8):619-627. doi: 10.1097/NMD.0000000000001172. J Nerv Ment Dis. 2020. PMID: 32433200 Review.
-
Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr. Report No.: 14-05207-EF-1. PMID: 24783270 Free Books & Documents. Review.
-
[Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].Epidemiol Prev. 2017 Sep-Dec;41(5-6):279-293. doi: 10.19191/EP17.5-6.AD01.069. Epidemiol Prev. 2017. PMID: 29119763 Review. Italian.
-
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.Medicina (Kaunas). 2019 Aug 23;55(9):525. doi: 10.3390/medicina55090525. Medicina (Kaunas). 2019. PMID: 31450833 Free PMC article.
Cited by 20 articles
-
A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019.Med Cannabis Cannabinoids. 2021 Feb 25;4(1):21-42. doi: 10.1159/000515069. eCollection 2021 Jun. Med Cannabis Cannabinoids. 2021. PMID: 34676348 Free PMC article.
-
Cannabis in the management of PTSD: a systematic review.AIMS Neurosci. 2021 May 13;8(3):414-434. doi: 10.3934/Neuroscience.2021022. eCollection 2021. AIMS Neurosci. 2021. PMID: 34183989 Free PMC article. Review.
-
Effects of ∆9-tetrahydrocannabinol on aversive memories and anxiety: a review from human studies.BMC Psychiatry. 2020 Aug 26;20(1):420. doi: 10.1186/s12888-020-02813-8. BMC Psychiatry. 2020. PMID: 32842985 Free PMC article. Review.
-
Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population.J Gen Intern Med. 2020 Jul;35(7):1979-1986. doi: 10.1007/s11606-020-05800-7. Epub 2020 Apr 6. J Gen Intern Med. 2020. PMID: 32291715 Free PMC article.
-
Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.Psychopharmacology (Berl). 2020 Jun;237(6):1813-1826. doi: 10.1007/s00213-020-05499-8. Epub 2020 Mar 11. Psychopharmacology (Berl). 2020. PMID: 32162103 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical